Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method

References

• Alluri H, Wiggins-Dohlvik K, Davis ML, et al. (2015). Blood-brain barrier dysfunction following traumatic brain injury. Metab Brain Dis 30:1093–104.
   PubMed Web of Science ®Google Scholar
• Aylward LL, Collins JJ, Bodner KM, et al. (2013). Elimination rates of dioxin congeners in former chlorophenol workers from Midland, Michigan. Environ Health Perspect 121:39–45.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo J, Tang Y, et al. (2015). Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry. J Pharm Biomed Anal 112:60–9.
   PubMed Web of Science ®Google Scholar
• Corps KN, Roth TL, McGavern DB. (2015). Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72:355–62.
   PubMed Web of Science ®Google Scholar
• Fu C, Wu Q, Zhang Z, et al. (2019). UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injury. J Ethnopharmacol 245:112149.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang Y, Huang X, et al. (2014). Determination of hydroxysafflor yellow A in biological fluids of patients with traumatic brain injury by UPLC-ESI-MS/MS after injection of Xuebijing. Biomed Chromatogr 28:1090–5.
   PubMed Web of Science ®Google Scholar
• Habgood MD, Bye N, Dziegielewska KM, et al. (2007). Morganti-Kossmann C and Saunders NR: changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eur J Neurosci 25:231–8.
   PubMed Web of Science ®Google Scholar
• Kou K, Hou XY, Sun JD, Chu K. (2014). Current pre-hospital traumatic brain injury management in China. World J Emerg Med 5:245–54.
   PubMedGoogle Scholar
• Liu Y, Lian Z, Zhu H, et al. (2013). A systematic, integrated study on the neuroprotective effects of hydroxysafflor yellow A revealed by (1)H NMR-based metabonomics and the NF-κB pathway. Evid Based Complement Altern Med 2013:147362.
   PubMedGoogle Scholar
• Marin JR, Weaver MD, Yealy DM, Mannix RC. (2014). Trends in visits for traumatic brain injury to emergency departments in the United States. JAMA 311:1917–9.
   PubMed Web of Science ®Google Scholar
• Rosenfeld JV, Maas AI, Bragge P, et al. (2012). Early management of severe traumatic brain injury. Lancet 380:1088–98.
   PubMed Web of Science ®Google Scholar
• Roozenbeek B, Maas AI, Menon DK. (2013). Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol 9:231–6.
   PubMed Web of Science ®Google Scholar
• Scheff SW, Ansari MA. (2017). Natural compounds as a therapeutic intervention following traumatic brain injury: the role of phytochemicals. J Neurotrauma 34:1491–1510.
   PubMed Web of Science ®Google Scholar
• Stocchetti N. (2014). Traumatic brain injury: problems and opportunities. Lancet Neurol 13:14–6.
   PubMed Web of Science ®Google Scholar
• Sun ML, Ma DH, Liu M, et al. (2009). Successful treatment of paraquat poisoning by Xuebijing, an injection concocted from multiple Chinese medicinal herbs: a case report. J Altern Complement Med 15:1375–8.
   PubMed Web of Science ®Google Scholar
• Jiang T, Liao Z, Dan W, et al. (2012). Xuebijing injection protects rats against traumatic brain injury. J Third Military Med Univ 34:307–10.
   Google Scholar
• Wang L, Liu Z, Dong Z, et al. (2016). Effects of Xuebijing injection on microcirculation in septic shock. J Surg Res 202:147–54.
   PubMed Web of Science ®Google Scholar
• Wang P, Song Y, Liu Z, et al. (2016). Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial. Trials 17:142.
   PubMedGoogle Scholar
• Wang Y, Zhang C, Peng W, et al. (2016). Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury. Mol Med Rep 14:3690–6.
   PubMed Web of Science ®Google Scholar
• Watzlawick R, Howell DW, Schwab JM. (2016). Neuroprotection after traumatic brain injury. JAMA Neurol 73:149–50.
   PubMed Web of Science ®Google Scholar
• Woodcock T, Morganti-Kossmann MC. (2013). The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18.
   PubMed Web of Science ®Google Scholar
• Xing Z, Xia Z, Peng W, et al. (2016). Xuefu Zhuyu decoction, a traditional Chinese medicine, provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway. Sci Rep 6:20040.
   PubMed Web of Science ®Google Scholar
• Yuan X, Bian X, Qi C. (2009). The protective effects of Xuebijing on rats after traumatic brain injury. J Jiangsu Univ (Medicine Edition) 19:35–8.
   Google Scholar
• Yang B, Wang Z, Sheng C, et al. (2016). Evidence-based review of oral traditional Chinese medicine compound recipe administration for treating weight drop-induced experimental traumatic brain injury. BMC Complement Altern Med 16:95.
   PubMed Web of Science ®Google Scholar
• Zhao W, Li K, Zhang SS, et al. (2014). The effect of Xuebijing injection on immune regulation in SIRS patients. Sichuan Da Xue Xue Bao Yi Xue Ban 45:863–5.
   PubMedGoogle Scholar
• Zhong Y, Luo J, Tang T, et al. (2018). Exploring pharmacological mechanisms of Xuefu Zhuyu decoction in the treatment of traumatic brain injury via a network pharmacology approach. Evid Based Complement Altern Med 2018:1.
   Google Scholar
• Zou L, Sun Z, Hu Y, et al. (2017). Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis. J Pharm Biomed Anal 137:220–8.
   PubMed Web of Science ®Google Scholar